AU Patent

AU2012257513B2 — Macrocyclic compounds as protein kinase inhibitors

Assigned to Fundacion del Sector Publico Estatal Centro Nacional de Investigaciones Oncologicas Carlos III FSP CNIO · Expires 2017-05-11 · 9y expired

What this patent protects

There is provided compounds of formula I, wherein R1, R

USPTO Abstract

There is provided compounds of formula I, wherein R1, R

Drugs covered by this patent

Patent Metadata

Patent number
AU2012257513B2
Jurisdiction
AU
Classification
—
Expires
2017-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Fundacion del Sector Publico Estatal Centro Nacional de Investigaciones Oncologicas Carlos III FSP CNIO
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.